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Abstract 
Introduction: A previous local study by 
Agius et al. published in MMJ in 20091 
identified a rise in lung adenocarcinoma 
over a decade, as well as an increasing 
number of females diagnosed with lung 
malignancy. 
Aims and Objectives: The aim of this 
retrospective study was to further compare 
trends in lung malignancy diagnosis made 
from bronchoscopy in Malta to previous 
local data. 
Materials and Methods: All 
bronchoscopies performed by one 
respiratory firm at Mater Dei Hospital in 
2014-2015 were analysed, excluding those 
performed in intensive care. Cytology and 
histology results were retrieved and 
compared to those obtained from previously 
studied timeframes. Patients who had a post-
bronchoscopy diagnosis via other means, 
were noted in order to calculate the 
bronchoscopy pick-up rate. 
Results: 118 bronchoscopies were 
performed, 101 of which were done for 
suspected malignancy. 48 patients were 
diagnosed with lung malignancy from 
bronchoscopy in 2014-2015 by this 
respiratory firm. When compared to 2006-
2007, 83.3% were males (vs 75%) and 
16.7% were females (vs 25%). The overall 
bronchoscopy pick-up rate for malignancy 
was 81.4%. The most common histological 
diagnoses, when compared to 8 years 
previously, were adenocarcinoma 35.4% vs 
27.8% (males 37.5% vs 31%; females 25% 
vs 14.3%), squamous cell 35.4% vs 44.4% 
(males 37.5% vs 44.8%; females 25% vs 
42.9%), and small cell 14.6% vs 13.9%.
Conclusion: Lung adenocarcinoma has 
shown an upward trend in both gender 
groups, having now reached a similar 
prevalence to squamous cell carcinoma, 
which appears to be decreasing in both 
males and females in the Maltese 
population. 
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Introduction 
Worldwide trends in primary lung 
malignancy have shown a rise in 
adenocarcinoma.  This is now the most 
common histological subtype worldwide2, 
surpassing squamous cell which was 
historically the most frequent. 
A 2009 Maltese study1 compared trends 
in bronchoscopic findings over a decade by 
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studying three 2-year periods: 1995-1996, 
1999-2000 and 2006-2007. The study 
identified a local rise in adenocarcinoma 
reflecting international statistics; however 
squamous cell carcinoma remained the most 
common subtype. 
International trends indicate a rising 
incidence of lung cancer in women. The 
2009 local study also revealed an increasing 
number of females diagnosed with lung 
malignancy over a decade.  
This 2014-2015 local project aimed to 
study the bronchoscopic diagnoses of lung 
cancer and compare them to the data from 
1995-1996, 1999-2000 and 2006-2007, and 
to identify whether local data shadows 
worldwide trends in the rise of lung 
adenocarcinoma. 
 
Materials and Methods 
Inclusion and Exclusion Criteria 
All patients who had a flexible 
bronchoscopy at Endoscopy Unit, Mater Dei 
Hospital under the care of one respiratory 
physician between January 2014 and 
December 2015 were included in the study. 
Patients who had a bronchoscopy in the 
Intensive Therapy Unit were not included.  
 
Data Collection 
Patient gender, age, smoking history 
and presenting symptoms were recorded 
from the bronchoscopy reports. The 
presence or absence of macroscopic 
abnormality on bronchoscopy was also 
recorded from the bronchoscopy sheet. The 
pre-bronchoscopy Chest X-rays and 
Computed Tomography (CT) scans were 
reviewed on Picture Archiving and 
Communication System (PACS®) and the 
results were noted.  
The presence or absence of sputum 
studies, bronchial washings, bronchial 
brushings and endobronchial biopsies was 
noted from iSoft Clinical Manager®. The 
final cytology or histology outcome was 
recorded for each patient, and the 
availability of immunohistochemistry was 
documented. 
Patients who had a post-bronchoscopy 
cancer diagnosis via other means such as 
radiologically-assisted biopsy and surgery, 
were also noted in order to calculate the 
bronchoscopy pick-up rate. 
 
Data Analysis 
The data for malignancy patients was 
compared with those from a similar study 
recording malignancy data from 1995-1996, 
1999-2000 and 2006-2007. 
 
Results 
A total of 118 bronchoscopies were 
performed by one respiratory firm between 
January 2014 and December 2015, 101 of 
which were done for suspected malignancy. 
Of these, 48 (46.7%) had a malignant 
diagnosis from bronchoscopy. 
 
Demographics 
The mean age of our cohort with lung 
malignancy was 67 years, with a range of 49 
to 87, and a median of 67.5 years. 40 
patients (83.3%) were male, and the 
remaining 8 (16.7%) were female. Fig. 1 
shows the trends in gender ratio, in 
comparison with previous local data. 
 
Smoking History 
Of the patients diagnosed with 
malignancy from bronchoscopy, 23 patients 
(47.9%) were current smokers, 17 (35.4%) 
were ex-smokers, 7 (14.6%) were non-
smokers, and the remaining patient had no 
smoking history documented. Fig. 2 shows 
the trends in smoking history in males and 
females separately over the past two 
decades. 
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Figure 1: Gender Distribution of Malignancy Patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Smoking History of Malignancy Patients 
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Figure 3: Presenting Symptom of Malignancy Patients 
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Fig. 3 shows the trends in presenting 
complaint, in comparison with previous 
data. Persistent cough was the most common 
presenting symptom in the 2014-2015 
cohort, followed by shortness of breath. 
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abnormal chest X-ray prior to 
bronchoscopy. 1 patient had a normal X-ray, 
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All patients had an abnormal pre-
bronchoscopy CT thorax. 
 
Sputum yield 
Sputum studies were largely unreliable 
since many samples were sub-optimal. 5 
patients (10.4%) had a malignancy diagnosis 
from sputum cytology. 
 
Bronchoscopic yield (Figs. 4 and 5).  
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malignancy from bronchoscopy, 44 patients 
(91.7%) had a macroscopic abnormality on 
bronchoscopy, while the remaining 4 (8.3%) 
had a macroscopically normal 
bronchoscopy. All patients had bronchial 
washings or lavage taken, and 40 were 
positive. The positive yield of bronchial 
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who had a malignant diagnosis made from 
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considering those patients who had a 
malignant diagnosis made from 
bronchoscopy was 81.3% (39 out of 48). 
35.4% (17 patients) had an endobronchial 
biopsy, of which 13 were positive. The 
positive yield of endobronchial biopsy when 
considering those patients who had a 
malignant diagnosis made from 
bronchoscopy was 76.5% (13 out of 17). 
 
 
Figure 4: Bronchoscopic Procedures Performed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Bronchoscopic Yield 
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Bronchoscopy pickup rate 
Although 48 patients were given a 
diagnosis of malignancy through 
bronchoscopic results, a further 11 patients 
had a negative bronchoscopy which was 
followed by a diagnosis of lung malignancy 
through other means. The overall 
bronchoscopy pick-up rate for malignancy 
was therefore 81.4% (48 out of 59 patients).  
Of those patients who had a negative 
bronchoscopy but were eventually 
diagnosed with lung malignancy through 
alternative means, 72.7% (8 out of 11) were 
diagnosed with adenocarcinoma. There was 
one patient each for squamous cell 
carcinoma and small cell carcinoma, and the 
remaining patient had a biopsy showing 
necrotic cells likely originating from 
necrotic areas of carcinoma but no definitive 
diagnosis could be established. Of this same 
patient cohort, 72.7% (8 out of 11) presented 
with persistent cough, while only 9.1% (1 
patient) presented with dyspnoea. 
The pickup rate of bronchial washings 
for malignancy was 67.8% (40 out of 59 
patients) and that of bronchial brushings was 
67.2% (39 out of 58 patients). The pickup 
rate of endobronchial biopsies was 68.4% 
(13 out of 19 patients). 
Histological subtypes 
Fig. 6 shows the histological subtypes 
diagnosed from bronchoscopy. The 
prevalence of adenocarcinoma is equal to 
that of squamous cell carcinoma in the 
2014-2015 cohort. There were no patients 
diagnosed with large cell carcinoma in the 
2014-2015 group. Immunohistochemistry 
results were available for 21 patients 
(33.9%). 
Figure 6: Final Malignant Diagnosis from Bronchoscopy 
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In the male cohort, adenocarcinoma 
and squamous cell carcinoma were equally 
prevalent (15 patients – 37.5%). These were 
followed by small cell carcinoma (14.6% or 
7 patients). There were no males diagnosed 
with adenosquamous carcinoma. The 
lymphoma and undifferentiated carcinoma 
patients were all male, and one of the 
patients with unspecified non-small cell 
carcinoma was male. 
The female cohort showed an equal 
distribution between adenocarcinoma, 
squamous cell carcinoma and 
adenosquamous carcinoma, each accounting 
for 25% (2 patients). 1 patient had small cell 
carcinoma, and the remaining patient was 
diagnosed with unspecified non-small cell 
carcinoma. 
Of those 6 patients presenting with 
brain metastasis who had a positive 
bronchoscopy, 3 patients were diagnosed 
with adenocarcinoma, 2 patients with 
squamous cell carcinoma and the remaining 
patient was diagnosed with unspecified non-
small cell carcinoma. 
 
Discussion 
Molecular profiling studies serve to 
remind us that lung cancer is a complex 
disease, with different phenotypes that are 
characterized by variation in morphology as 
well as molecular composition. Over recent 
decades, there appears to be worldwide 
shifts in the relative frequencies of various 
phenotypic patterns of lung cancer, which 
are even more striking than changes in the 
overall incidence of lung cancer.3 
When comparing presenting symptoms 
of lung malignancy over the years, it is 
noticeable that in our local cohort of 
patients, cough (41.7% of patients with a 
positive bronchoscopy) and dyspnoea 
(35.4%) have become more common, 
possibly explained by the fact that medical 
practitioners are investigating these 
symptoms more thoroughly. Cough was 
even more common among malignancy 
patients with a negative bronchoscopy 
(72.7%); these patients most likely had 
peripheral tumours, and the cough suggests 
involvement of peripheral nerves. In 
contrast, patients with a positive 
bronchoscopy were more likely to present 
with dyspnoea (35.4%) than those with a 
negative bronchoscopy who were diagnosed 
with malignancy through other means 
(9.1%). This is probably because patients 
with a positive bronchoscopy had central 
lesions which compromise more lung 
function. 
Unfortunately, a larger number of 
patients presented with brain metastasis 
when compared to the previous 15 years. 
The incidence in our local cohort (12.5%) is 
similar to that quoted in a study performed 
by Shouten et al.4 (16.3%). All cases of 
brain metastases occurred in conjunction 
with non-small cell lung cancer. Although 
small cell lung cancer classically carries a 
high risk of brain metastases, non-small cell 
lung cancer is also commonly associated 
with brain metastases and the risk can be as 
high as 23.2%.5 The absence of small cell 
lung cancer patients with brain metastases is 
probably due to the fact that small cell lung 
cancer was diagnosed in only a small 
percentage of our cohort (14.6%). 
Previous local data identified a 
persistent decrease in the male:female ratio 
for lung malignancy, reflecting international 
trends. This trend was not reflected in our 
study, and the significance of the drop in 
females is unclear. International studies 
have also shown an increase in lung cancer 
in never-smokers, and the reasons for this 
remain uncertain.6 Our local data show a 
small decline in the percentage of male lung 
malignancy patients with a positive smoking 
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history over recent years, while there is no 
consistent trend in the female smoking 
history, with females having a positive 
smoking history varying from 16 to 67% 
over the last two decades. 
When comparing diagnostic methods 
performed during bronchoscopy, a 
significant improvement in the lavage is 
noticeable. However, these results were not 
mirrored in the results obtained from the 
bronchial brushings. A plausible explanation 
could be the introduction of different 
branded bronchial brushes in our hospital, 
with the resulting technical difficulties 
associated with them. Results of 
endobronchial biopsies have given similar 
yields possibly due to that fact that more 
experienced staff tend to perform such a 
procedure, while brushings are usually 
carried out by respiratory trainees 
performing the bronchoscopy under 
supervision.  
The bronchoscopy pick-up rate for 
malignancy of 81.4% was calculated by 
following up those patients who had a 
negative bronchoscopy but were diagnosed 
with lung malignancy through alternative 
means. The previous local study by Agius et 
al. did not follow up patients in this manner, 
and therefore do not quote any pick-up rates. 
Our results show that most lung cancer 
patients who had a negative bronchoscopy 
were diagnosed with adenocarcinoma 
(72.7%), and this is probably because 
adenocarcinoma tends to be peripheral and 
therefore less amenable to bronchoscopic 
techniques. 
Previous results have shown that 
squamous cell carcinoma was the most 
frequent histological subtype; however, our 
recent study has shown that adenocarcinoma 
and squamous cell carcinoma are equally 
diagnosed. Histology trends show a 
persistent upward trend in the 
adenocarcinoma histological subtype in both 
males (37.5% in our cohort vs 31% in the 
2006-2007 cohort) and females (25% vs 
14.3%), and a decline in the squamous cell 
carcinoma subtype in both gender groups 
(males 37.5% vs 44.8%; females 25% vs 
42.9%). International studies have also 
identified similar trends with a significant 
increase in the incidence rate of 
adenocarcinoma and drop in the rate of 
squamous cell carcinoma.2,7-11 The 
increasing proportion of lung cancers 
classified as adenocarcinoma has been a 
topic of interest and research for a number 
of years. To date, the cause of the increase 
in adenocarcinomas is not clear. Two 
changes in cigarette design over time have 
been proposed to explain the rise of 
adenocarcinoma in females. First, ventilated 
filters, which have gained popularity over 
the last several decades, have led to 
compensatory smoking, where smokers 
inhale a greater volume of smoke more 
deeply, leading to increased exposure of 
cells on the periphery of the lung (where 
adenocarcinoma occurs) to carcinogens. 
Secondly, filtered cigarettes are richer in 
nitrate, increasing the exposure to N-
nitrosamines, which are associated with an 
increased risk for adenocarcinoma but not 
with other types of lung cancer.7 
A similar number of bronchoscopies 
has been performed during the study period 
compared to the previous study, despite the 
increasing number of CT-guided lung 
biopsies performed in our hospital. This 
implies that there is a probable overall 
increase in the incidence of lung malignancy 
locally. In our study, we also looked at 
patients who had suspected malignancy 
whose eventual malignant diagnosis was 
made from CT-guided biopsy following a 
negative bronchoscopy, whereas in the 
previous study, such patients were not taken 
13
OrgOdRe Original Article 
 Malta Medical School Gazette     Volume 01 Issue 04 2017 
into consideration, possibly due to the fact 
that there were no patients who had a CT-
guided biopsy performed following a normal 
bronchoscopy, since the procedure was not 
available at the time. 
Limitations of the Study 
Patients who never had a bronchoscopy 
but were diagnosed with lung malignancy 
through radiologically-assisted biopsy or 
other means, were not included in the study. 
This implies that the results of the study 
may not be totally representative of the lung 
malignancy trends in Malta. Only the results 
of one of four respiratory consultants’ 
bronchoscopies were analysed. Since 
bronchoscopy results tend to depend on the 
operator performing the procedure, one 
respiratory firm was chosen in order to 
standardize the bronchoscopy procedure as 
much as possible. 
Conclusion 
Adenocarcinoma has increased in both 
males and females separately in Malta, and 
now has a similar prevalence to squamous 
cell carcinoma. On a positive note, several 
genetic mutations specific to lung 
adenocarcinomas have been found, 
representing attractive targets for molecular 
therapy. 
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